| Bioactivity | 2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine |
| CAS | 1613530-52-1 |
| Formula | C18H22N2O10S |
| Molar Mass | 458.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine
CAS: 1613530-52-1 F: C18H22N2O10S W: 458.44
2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.